Atlas Trials

Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function

Clinical trial NCT02412098 · COMPLETED

Trial details

NCT number
NCT02412098
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Long QT Syndrome
Start date
2015-03-19
Primary completion
2016-04-22
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.